CXCR4 and acute myeloid leukemia: Thus, inhibition might both reduce the homing to the hematopoietic niche and induce a more vigorous mobilization of leukemic cells and the LSC, as seen by Jia and colleagues when they combined targeting of CXCR4 and E-selectin/CD62E in vitro in AML ​ [18].